C81.26
Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Mixed cellularity Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, which is part of the body's immune system. It specifically affects the lymph nodes located within the pelvic region. As a subtype of Hodgkin lymphoma, this disease is characterized by the presence of Reed-Sternberg cells in affected tissues. Recognizing and diagnosing this condition early is important for effective treatment options. This guide provides an overview of its causes, symptoms, diagnosis, and potential treatments to help patients and their loved ones better understand this medical condition.
Causes & Symptoms
Clinical Causes: Genetic factors and family history may increase susceptibility. Infection with the Epstein-Barr Virus (EBV) has been associated with the development of Hodgkin lymphoma. Weakened immune system, either due to other illnesses or immunosuppressive therapies, can increase risk. Previous exposure to radiation or certain chemicals may contribute to the disease.
Key Symptoms: Swelling or painless lumps in the pelvic region or lymph nodes. Persistent fatigue and weakness. Unexplained weight loss over a short period. Fever that does not resolve. Night sweats, often severe enough to require changing clothing or bedding. Itching skin, without an apparent cause. Unexplained weight loss and loss of appetite. Abdominal discomfort or swelling if the lymph nodes press on nearby organs.
Diagnostic & Treatment
Diagnosis Path: The diagnosis of mixed cellularity Hodgkin lymphoma involves several steps:
Treatment Protocols: Treatment strategies for mixed cellularity Hodgkin lymphoma usually involve combined approaches, tailored to the stage and individual's health:
Clinical Advice & FAQs
Billing Guidance
Is C81.26 a billable ICD-10 code?
Yes, C81.26 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.26?
Clinical documentation must specify the nature of Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference